Literature DB >> 16000554

Lysophosphatidic acid, a disintegrin and metalloprotease-17 and heparin-binding epidermal growth factor-like growth factor in ovarian cancer: the first word, not the last.

Ada H Braun1, Robert J Coffey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16000554     DOI： 10.1158/1078-0432.CCR-05-0973

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  5 in total

1.  Toward an integrative analysis of the tumor microenvironment in ovarian epithelial carcinoma.

Authors:  Ryan N Serio
Journal:  Cancer Microenviron       Date:  2011-11-23

Review 2.  Trafficking of epidermal growth factor receptor ligands in polarized epithelial cells.

Authors:  Bhuminder Singh; Robert J Coffey
Journal:  Annu Rev Physiol       Date:  2013-11-08       Impact factor: 19.318

Review 3.  Activated epidermal growth factor receptor in ovarian cancer.

Authors:  Laurie G Hudson; Reema Zeineldin; Melina Silberberg; M Sharon Stack
Journal:  Cancer Treat Res       Date:  2009

Review 4.  EGF-receptor regulation of matrix metalloproteinases in epithelial ovarian carcinoma.

Authors:  Laurie G Hudson; Natalie M Moss; M Sharon Stack
Journal:  Future Oncol       Date:  2009-04       Impact factor: 3.404

5.  ADAM17 silencing in mouse colon carcinoma cells: the effect on tumoricidal cytokines and angiogenesis.

Authors:  Sudipta Das; Maria Czarnek; Monika Bzowska; Renata Mężyk-Kopeć; Krystyna Stalińska; Barbara Wyroba; Jolanta Sroka; Jarosław Jucha; Dawid Deneka; Paulina Stokłosa; Justyna Ogonek; Melody A Swartz; Zbigniew Madeja; Joanna Bereta
Journal:  PLoS One       Date:  2012-12-10       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.